Item 7.01. Regulation FD Disclosure.
During a meeting with a research analyst November 25, 2025, Albany International Corp. (the "Company") provided certain additional information relating to its previously announced exploration of strategic alternatives for its structures assembly business, including a potential sale of all or a part of the business at the Amelia Earhart Drive Facility (the "AED Facility") in Salt Lake City. In particular, the following information was provided:
•The Company is in the process of selecting a financial advisor and developing financial models with respect to the AED Facility, which it may market as a whole. The Company does not have an estimate on how long it expects this will take.
•Interest to date has been from private equity investors, with more than ten inbound inquiries so far, rather than strategic investors.
•As previously disclosed, as part of the strategic alternatives, the Company is in ongoing discussions with its customer about potential contract modifications to offset cost increases.
•The Company's expectation is that, if a divestiture of the AED Facility is completed, the Adjusted EBITDA margin for the Albany Engineered Composites business segment will be in the mid to high teens.
This Current Report on Form 8-K (this "Report") is being furnished solely to satisfy the Company's obligations under Regulation FD in light of the inadvertent selective disclosure of potentially material information. The Company reiterates that while it cannot guarantee a specific outcome or timeline, its decisions will be guided by the best interests of the Company and its shareholders.
The information in this Report on Form 8-K is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act. This Report will not be deemed an admission as to the materiality of any information contained herein.
Non-GAAP Measures
This Report references a non-GAAP measure, Adjusted EBITDA margin, that should not be considered in isolation or as a substitute for the related GAAP. Management believes that this non-GAAP measure provides additional useful information to investors regarding the Company's operational performance.
Adjusted EBITDA is a performance measures that relates to the Company's continuing operations. The Company defines Adjusted EBITDA as EBITDA (calculated as net income excluding interest, income taxes, depreciation and amortization) excluding costs or benefits that are not reflective of the Company's ongoing or expected future operational performance. Such excluded costs or benefits do not consist of normal, recurring cash items necessary to generate revenues or operate our business. Adjusted EBITDA margin represents Adjusted EBITDA expressed as a percentage of net revenues.
The Company encourages investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.
Forward-Looking Statements
This Current Report on Form 8-K may contain statements, estimates, guidance or projections that constitute "forward-looking statements" as defined under U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," "should," "look for," "guidance," "guide," and similar expressions identify forward-looking statements, which generally are not historical in nature. Because forward-looking statements are subject to certain risks and uncertainties (including, without limitation, those set forth in the Company's most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q), actual results may differ materially from those expressed or implied by such forward-looking statements.